Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Roxy Senior Added: 3 years ago
Stress echocardiography, which was introduced in the early 1980s, has matured to a reliable cost-effective method for diagnosing and risk-stratifying patients with suspected or known coronary artery disease (CAD). The use of stress echocardiography as the non-invasive method of choice for assessment of CAD has increased exponentially worldwide. In the US alone, approximately three million stress… View more

Imaging & Diagnostics
The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
Author(s): Eliecer Coto , Pablo Avanzas , Juan Gómez Added: 3 years ago

COVID-19

Prevention & Chronic Conditions
Author(s): Joakim Alfredsson , Eva Swahn Added: 3 years ago
Cardiovascular diseases are the leading cause of death in industrialised countries; among these, coronary artery disease (CAD) is the most prevalent and is associated not only with high mortality but also with substantial morbidity. Acute manifestations of CAD are ST-elevation myocardial infarction (STEMI), non-STEMI (NSTEMI), unstable angina pectoris (UAP) and sudden ischaemic death.1 Due to the… View more

Prevention & Chronic Conditions

MI/ACS
Author(s): WY Wandy Chan , Richard W Troughton Added: 3 years ago
Acute coronary syndromes (ACS) and acute pulmonary embolism (APE) are leading causes of hospital admission and mortality. Accurate risk stratification is important for both conditions to guide management and the use of therapies that lead to improved outcomes. Acute Coronary Syndromes Despite a steady decline in developed countries, ischaemic heart disease is still the leading cause of death… View more

MI/ACS
Author(s): Robert Campbell , Peter Fischbach , Patricio Frias , et al Added: 3 years ago
White and Eustis were the first to document congenital complete heart block (CCHB) with electrocardiogram in 1921. Until the 1950s, CCHB without structural heart disease was considered rare and benign. CCHB is estimated to complicate one in 15,000–22,000 live births; however, the true incidence of CCHB is unknown as there is an association with structural congenital heart disease (CHD) with a… View more

Heterogeneous Populations
Non-invasive Evaluation of Coronary Flow Reserve in Cardiac Syndrome X Patients
Author(s): Elsayed Abd-El-kader Elsayed Added: 11 months ago

Imaging & Diagnostics
SUGAR: Amphilimus-eluting Stents VS Zotarolimus-eluting Stents in Patients With DB
Author(s): Rafael Romaguera Added: 2 years ago
In this short interview, Dr Rafael Romaguera (University of Barcelona, SP) discusses the findings from the SUGAR trial.This randomized head-to-head trial aimed to compare Cre8 EVO stents to a contemporary drug-eluting stent (DES) in patients with diabetes (DM) and coronary artery disease. The trial, first presented at TCT 2021, demonstrated that Cre8 EVO stents were non-inferior to Resolute Onyx… View more

Prevention & Chronic Conditions
EHRA 23: ANTWOORD II: LVEF Recovery After AF Ablation in HF Patients
Author(s): Marco Bergonti Added: 12 months ago
EHRA 23 - Dr Marco Bergonti (Istituto Cardiocentro Ticino, CH) to discuss the key takeaways from the ANTWOORD II Trial. In this study, 605 heart failure patients undergoing atrial fibrillation ablation were enrolled to receive an ANTWERP Score, which aimed to predict LVEF recovery. 70% of patients were categorised as 'responders', patients identified as those who could benefit the most from AF… View more

Heart Failure

Electrophysiology & Arrhythmia
Author(s): Adrian JB Brady Added: 3 years ago
Hypertension is the single most important preventable cause of premature death in the Western world. The quest to find the most effective treatment both in terms of blood pressure control and prevention of events, such as heart attacks and strokes, is on-going. The issue of which antihypertensive agent to use first-line has been the subject of debate for over two decades. The lack of a coherent… View more

Prevention & Chronic Conditions

Heterogeneous Populations
Dysphagia and the Management of Patients in Need of Lipid-Lowering
Author(s): Yassir Javaid , , Added: 1 year ago
This virtual round table series focuses on dysphagia and the management of patients in need of lipid-lowering medications. The first three sessions of this video series are presented by Dr Yassir Javaid (Northamptonshire CCG, UK), Prof Nina Barnett (London North West University Healthcare NHS Trust, UK) and Mr Paresh Parmar (London North West Healthcare NHS Trust, UK) followed by session four, a… View more

Standards & Guidelines

Prevention & Chronic Conditions